Holen Sie sich die Stockscreener-App
5.06
1.36%
-0.07
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
EBIT of Harvard Bioscience, Inc. – MUN:HBI0 - TradingView
HARVARD BIOSCIENCE (NASDAQ: HBIO) CEO receives 75,000-share stock grant - Stock Titan
William Snider Secures Board Seat at Harvard Bioscience with 15.97% Stake - TradingView
BroadOak reports 16% Harvard Bioscience (HBIO) stake tied to loans and warrants - Stock Titan
Harvard Bioscience stock faces scrutiny amid Q4 earnings anticipation and life sciences sector volat - AD HOC NEWS
Taxes of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience Outlines Post-Refi Strategy, Organoid Growth Focus - National Today
Total equity of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LS:A423J5 - TradingView
Free cash flow per share of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView
Equity in earnings of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Cash per share of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Harvard Bioscience, Inc. Cash Flow – GETTEX:HBI0 - TradingView
Net income of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
Price to earnings ratio of Harvard Bioscience, Inc. – GETTEX:HBI0 - TradingView
Net debt of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Return on assets % of Harvard Bioscience, Inc. – LSX:A423J5 - TradingView
Harvard Bioscience, Inc. Revenue Breakdown – LSX:A423J5 - TradingView
Insider Buying: Stephen Denelsky Acquires 10,000 Shares of Harva - GuruFocus
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares By Investing.com - Investing.com India
Harvard Bioscience (HBIO) director Denelsky buys $48,700 in shares - Investing.com
Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares - MarketBeat
Harvard Bioscience (HBIO) director buys 10,000 shares in open market - Stock Titan
Harvard Bioscience director Snider buys $103,603 in HBIO stock By Investing.com - Investing.com India
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares - MarketBeat
Harvard Bioscience director Snider buys $103,603 in HBIO stock - Investing.com
Harvard Bioscience (HBIO) director buys 21,000 shares on open market - Stock Titan
HBIO Stock Price, Quote & Chart | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
Harvard Bioscience CEO Duke buys $25k in shares By Investing.com - Investing.com Australia
Layoff Watch: What are analysts price targets for Harvard Bioscience IncTrade Analysis Report & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Insider Buying: John Duke Acquires 5,000 Shares of Harvard Biosc - GuruFocus
Harvard Bioscience CEO Duke buys $25k in shares - Investing.com
Harvard Bioscience (HBIO) CEO adds shares and holds major RSU awards - Stock Titan
Harvard Bioscience at KeyBanc Forum: Strategic Growth and Market Focus By Investing.com - Investing.com Canada
Harvard Bioscience outlines 2026 guidance with 2%–4% revenue growth and high-margin focus following structural improvements - MSN
Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - Minichart
Harvard Bioscience (HBIO) Earnings Transcript - AOL.com
Harvard Bioscience Highlights CFO Appointment and Strategic Repositioning - TipRanks
Market Trends: Whats next for Harvard Bioscience Inc stockRisk Management & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Harvard Bioscience provides investor presentation; FY25 results, FY26 guidance and strategic actions - TradingView
Harvard Bioscience (NASDAQ: HBIO) posts FY25 metrics and guides modest 2026 growth - Stock Titan
HBIO: Benchmark Raises Price Target to $6.00, Maintains Speculat - GuruFocus
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split - Investing.com Australia
Benchmark raises Harvard Bioscience stock price target to $6 on reverse split By Investing.com - Investing.com India
How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 Expectations - Yahoo Finance
Benchmark cuts Harvard Bioscience stock price target on NIH concerns - Investing.com Nigeria
HBIO: Analyst Bruce D. Jackson Maintains Rating but Lowers Price Target | HBIO Stock News - GuruFocus
Benchmark cuts Harvard Bioscience stock price target on NIH concerns By Investing.com - Investing.com South Africa
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience 2025 10‑K: Revenue $86.6M, Gross Profit $49.91M - TradingView
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high By Investing.com - Investing.com Canada
Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high - Investing.com
Harvard Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HBIO) 2026-03-13 - Seeking Alpha
Harvard Bioscience Q4 2025 Earnings Call Transcript - MarketBeat
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: - GuruFocus
0.03%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):